If you have pulmonary arterial hypertension, or PAH, it means that you have high blood pressure in your pulmonary arteries-- the blood vessels that carry blood from your heart to your lungs.

Gossamer Bio Inc. has released new data showing its inhaled kinase inhibitor, seralutinib, has long-lasting effects on ...

Merck MRK has decided to stop the phase III HYPERION study early. The study evaluates MRK’s pulmonary arterial hypertension ...

?] Pulmonary arterial hypertension happens when the arteries that carry blood from your heart to your lungs get narrow or blocked. This makes the blood pressure inside these arteries go up, and ...

Natco Pharma gains FDA approval for generic Bosentan tablets, partnering with Lupin Pharmaceuticals for U.S. marketing.

The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.

The HYPERION study will be stopped early due to positive efficacy data from across the sotatercept clinical program.

Seropositive rheumatoid arthritis may be protective against the development of PAH, based on results of Mendelian randomization analyses.

The phase 3 HYPERION trial of Winrevair in adults with newly diagnosed pulmonary arterial hypertension functional class two ...

All patients in the trial will have the opportunity to resume or begin treatment with Winrevair, the company said.

The Phase III HYPERION trial was stopped early after strong positive interim results from the ZENITH trial demonstrated the ...